Latest news
Loading news…
Allegria Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Basel, Basel-Stadt, Switzerland Founded 2023 1-10 employees For Profit
Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $243K
Company Info
- Founded
- 2023
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 13
- HQ
- Basel, Basel-Stadt, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- 0.2
- Trend (30d)
- -1.3
- Trend (90d)
- -4.5
- Last leadership hire
- Dec 11, 2025
Key People at Allegria Therapeutics
CEO & Co-founder
1
professional contacts at Allegria Therapeutics
Contact execs at Allegria Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Allegria Therapeutics
Loading news…
FAQs about Allegria Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.